ALBO
$18.75
Albireo Pharma
($.82)
(4.19%)
ALBO
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($1.90)
Revenue:  $8.77 Mil
Monday
Nov 14
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ALBO reports earnings?
Beat
Meet
Miss

Where is ALBO's stock price going from here?
Up
Flat
Down
Stock chart of ALBO
Analysts
Summary of analysts' recommendations for ALBO
Score
Grade
Pivots
Resistance
$21.50
$20.92
$20.24

$19.66

Support
$18.99
$18.41
$17.73
Tweet
Growth
Description
Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.